Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis. [electronic resource]
Producer: 20161005Description: 6719-26 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Bacterial -- blood
- Bacterial Outer Membrane Proteins -- administration & dosage
- Cohort Studies
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Immunoglobulin G -- blood
- Immunoglobulin M -- blood
- Lipopolysaccharides -- administration & dosage
- Male
- Meningococcal Infections -- prevention & control
- Meningococcal Vaccines -- administration & dosage
- Middle Aged
- Oligodeoxyribonucleotides -- administration & dosage
- Sepsis -- prevention & control
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.